You are here

Article Text

Article menu
Download PDFPDF
Short report
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease
  1. H Nagayama1,3,
  2. M Hamamoto1,3,
  3. M Ueda3,
  4. J Nagashima2,
  5. Y Katayama3
  1. 1Department of Neurology, Tokyo Metropolitan Tama Geriatric Hospital, Tokyo 189-8511, Japan
  2. 2Radiology, Tokyo Metropolitan Tama Geriatric Hospital
  3. 3Second Department of Internal Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan
  1. Correspondence to:
 Dr H Nagayama
 Second Department of Internal Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan; nagaya2attglobal.net

Abstract

Aim: To evaluate the reliability of [123I]meta-iodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson’s disease (PD).

Patients/Methods: A series of 391 outpatients showing one or more parkinsonian-like symptoms was longitudinally followed up for accurate clinical diagnosis. MIBG scintigraphy was performed in the patients and 10 normal controls of similar age. The heart to mediastinum uptake ratio was calculated in each person, and the values were considered abnormal if they were greater than two standard deviations below the control mean.

Results: MIBG uptake was decreased in most patients with PD (87.7%), and was seen in all advanced cases with Hohen-Yahr stage III or more; the sensitivity and specificity of scintigraphy for detecting PD were 87.7% and 37.4%, respectively. Surprisingly, over half of the patients without PD (66.5%) also exhibited low uptake, resulting in considerable overlap in the ratios between PD and the other disorders.

Conclusion: MIBG scintigraphy is a sensitive, but not specific, test for PD. Low MIBG uptake does not necessarily indicate PD, but is essential for diagnosing advanced PD.

  • CVD, cerebrovascular disease
  • DLB, dementia with Lewy bodies
  • H/M, heart to mediastinum
  • HY, Hohen-Yahr
  • MIBG, meta-iodobenzylguanidine
  • MSA, multiple system atrophy
  • PD, Parkinson’s disease
  • PSP, progressive supranuclear palsy
  • SDAT, senile dementia of Alzheimer type
  • Parkinson’s disease
  • myocardial scintigraphy
  • meta-iodobenzylguanidine

https://doi.org/10.1136/jnnp.2004.037028

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: none declared